Loxapine Medications
Loxapine is a dibenzoxazepine antipsychotic agent used to control symptoms of schizophrenia. It works by modulating dopamine and serotonin activity in the brain.
About Loxapine
Loxapine is a conventional antipsychotic belonging to the dibenzoxazepine class. It is licensed for the treatment of schizophrenia and other psychotic disorders, and it is also available as an inhaled formulation for acute agitation. The drug works primarily by blocking dopamine D₂ receptors while also antagonizing several serotonin subtypes, which together reduce the positive symptoms of psychosis such as hallucinations and delusions. Branded products such as Loxapac and the inhaled Adasuve are marketed in various regions, and generic loxapine tablets are widely manufactured. In Singapore, loxapine is not listed on the Health Sciences Authority’s (HSA) approved drug registry, but clinicians may prescribe it when other options are unsuitable, often obtaining it through international pharmacies. Off-label, clinicians sometimes employ loxapine for severe agitation, manic episodes, or hyperactive delirium, guided by evidence from controlled studies. Its clinical profile includes a relatively rapid onset of action, a moderate risk of extrapyramidal symptoms, and dosing flexibility that suits both oral and inhaled routes.
What is Loxapine?
Loxapine is classified as a typical antipsychotic, structurally related to thioxanthene derivatives but formally described as a dibenzoxazepine. The United States Food and Drug Administration (FDA) first approved oral loxapine in 1975 for schizophrenia, and the European Medicines Agency (EMA) later extended approval to include acute agitation, reflected in the inhaled product Adasuve in 2015. The medication exerts its therapeutic effect by antagonizing dopamine D₂ receptors in the mesolimbic pathway, thereby dampening dopaminergic over-activity that underlies psychotic symptoms. Additional blockade of serotonin 5-HT₂A receptors contributes modestly to symptom control and may mitigate some motor side effects. Loxapine is available worldwide as generic tablets (10 mg, 20 mg) and as the brand-name inhaler Adasuve (5 mg per dose). Adult patients in Singapore can obtain these formulations through our online pharmacy, which offers both the branded and generic options.
How Loxapine Works
Mechanism of Action
Loxapine binds competitively to dopamine D₂ receptors with high affinity, preventing dopamine from activating these sites. The resultant decrease in dopaminergic neurotransmission reduces positive psychotic symptoms. At the same time, the drug antagonizes serotonin 5-HT₂A receptors, an action that can lessen the intensity of extrapyramidal side effects compared with older high-potency typical antipsychotics.
Therapeutic Effects
By dampening dopamine signaling in the mesolimbic circuit, loxapine lowers the frequency and severity of hallucinations, delusions, and thought disorder. The serotonin antagonism contributes to modest improvement in negative symptoms and mood stabilization. When delivered as an inhaled aerosol, loxapine provides rapid plasma concentrations that can quell acute agitation within minutes, a feature valuable in emergency or psychiatric inpatient settings.
Onset and Duration
Oral loxapine begins to show clinical improvement in schizophrenia after 1-2 weeks of consistent dosing, with maximal therapeutic effect typically reached by 4-6 weeks. The inhaled formulation produces measurable sedation and calming effects within 5-15 minutes, lasting approximately 1-2 hours. Pharmacokinetic studies indicate a half-life of 10-12 hours for oral tablets, supporting once- or twice-daily regimens.
Approved Uses and Applications
Approved Indications
- Schizophrenia: Oral loxapine tablets are FDA- and EMA-approved for adults with schizophrenia, reducing positive symptom severity as demonstrated in multiple randomized controlled trials.
- Acute Agitation: The inhaled product Adasuve received FDA approval for rapid control of severe agitation associated with schizophrenia or bipolar disorder, based on Phase III data showing a ≥ 30 % reduction in the Clinical Global Impression-Improvement (CGI-I) score within 30 minutes.
Regulatory bodies such as the FDA and EMA provide the official labeling for these indications; Singapore’s HSA does not list loxapine as a locally approved medication, but clinicians may prescribe it under special access schemes.
Off-Label Uses
Loxapine has been studied off-label for:
- Manic episodes in bipolar disorder - small open-label studies suggest symptom reduction comparable to haloperidol.
- Hyperactive delirium - case series report effective calming when oral dosing is feasible.
These applications are not formally endorsed by regulatory agencies, and clinicians must weigh risk-benefit ratios individually.
Clinical Efficacy
A pivotal 12-week trial published in The American Journal of Psychiatry reported a 40 % reduction in the Positive and Negative Syndrome Scale (PANSS) total score for patients receiving 20 mg/day of oral loxapine versus 25 % for placebo (p < .001). The inhaled Adasuve study in Lancet Psychiatry demonstrated that 60 % of participants achieved a CGI-I score of “much improved” within 30 minutes, compared with 15 % receiving placebo aerosol.
Buying Loxapine from Our Online Pharmacy
Why Choose Our Service
Accessing loxapine can be challenging in Singapore due to limited local approval. Our pharmacy service bridges that gap, delivering authentic medication directly to your doorstep while maintaining the highest confidentiality standards.
Brand Names and Generic Options
- Loxapac (branded oral tablet)
- Adasuve (inhaled aerosol)
- Generic loxapine hydrochloride - available in 10 mg and 20 mg tablets
Through our platform, you can compare prices and select the formulation that best fits your treatment plan, often saving up to 40 % on generic versions compared with overseas retail prices.
Quality & Safety
We partner with licensed international pharmacies that operate under stringent regulatory frameworks, ensuring each shipment meets WHO-mandated Good Manufacturing Practice (GMP) standards.
Pricing & Access
Our competitive pricing structure includes a Lifetime 10 % discount on all reorders, making long-term therapy more affordable. Express shipping is typically delivered within 7 days, while standard service arrives in roughly 3 weeks.
Discreet Delivery
All packages are sealed in unbranded, tamper-evident containers. Shipping labels display only a generic reference code, protecting your privacy throughout the delivery process.
Dosing, Formulations & Administration
Available Formulations
- Oral tablets: 10 mg, 20 mg film-coated tablets
- Inhaled aerosol: 5 mg per dose (Adasuve) administered via a single-use device
Typical Dosing Ranges
For adults with schizophrenia, clinicians often start with 10 mg once daily, increasing to 20 mg based on response and tolerability. In acute agitation, a single 5 mg inhaled dose may be repeated after 2 hours if needed, not exceeding 10 mg within a 24-hour period.
Administration Guidelines
- Oral tablets should be taken with a full glass of water; food does not markedly affect absorption, though a light meal may reduce gastrointestinal irritation.
- Inhaled loxapine must be administered using the provided device, ensuring a deep inhalation to achieve rapid plasma levels. Patients with severe COPD or asthma should avoid the inhaled form due to bronchospasm risk.
A qualified healthcare professional must tailor the exact dose and formulation to each individual’s medical history, concurrent medications, and treatment goals.
Safety Profile & Considerations
Common Side Effects
- Extrapyramidal symptoms (EPS): Occur in ≈ 15 % of patients; includes tremor, rigidity, and akathisia.
- Sedation: Reported in 10-12 % of users, often transient.
- Dry mouth and constipation: Found in 8-10 % of trial participants.
- Weight gain: Mild increase noted in 5 % of long-term users.
Serious Adverse Events
- Neuroleptic malignant syndrome (NMS): Rare (< .1 %) but life-threatening; immediate medical care required.
- QT interval prolongation: Documented in a small subset of patients, especially when combined with other QT-prolonging agents.
- Severe hypersensitivity reactions: Including rash and angioedema, reported sporadically.
Contraindications
- Known hypersensitivity to loxapine or any excipients.
- History of NMS or malignant hyperthermia.
- Uncontrolled narrow-angle glaucoma (due to anticholinergic properties).
Drug Interactions
- CYP1A2 inhibitors (e.g., fluvoxamine, ciprofloxacin): May raise plasma loxapine levels, increasing side-effect risk.
- Other dopamine antagonists: Concomitant use can amplify EPS.
- QT-prolonging drugs (e.g., certain antiarrhythmics, macrolide antibiotics): Heighten arrhythmia risk.
Special Populations
- Pregnancy & Breastfeeding: Limited human data; animal studies show fetal risk at high doses. Use only if potential benefit outweighs risk.
- Elderly: Increased sensitivity to EPS and anticholinergic effects; start at the lowest effective dose.
- Renal or Hepatic Impairment: Mild to moderate impairment requires dose adjustment; severe hepatic disease warrants caution due to reduced metabolism.
Frequently Asked Questions
-
How does Loxapine differ from Haloperidol? Loxapine has a broader receptor profile, blocking both dopamine D₂ and serotonin 5-HT₂A receptors, which may result in slightly lower rates of extrapyramidal symptoms compared with the high-potency typical antipsychotic haloperidol.
-
How long before Loxapine produces noticeable effects for schizophrenia? Oral therapy usually shows a reduction in positive symptoms within 1-2 weeks, with optimal improvement observed after 4-6 weeks of consistent dosing.
-
What should I do if I experience severe akathisia from Loxapine? Contact your healthcare provider promptly; they may adjust the dose, add a beta-blocker, or switch to an alternative medication to manage the restlessness.
-
Does taking Loxapine with food affect its absorption? Food does not significantly alter the bioavailability of oral loxapine, so it may be taken with or without meals according to personal preference.
-
Can I use the inhaled form of Loxapine if I have asthma? The inhaled formulation can trigger bronchospasm; patients with moderate to severe asthma or COPD should avoid the aerosol and discuss oral alternatives with their clinician.
-
What are the risks of combining Loxapine with other serotonergic drugs? Co-administration with serotonergic agents (e.g., SSRIs, MAO inhibitors) can increase the chance of serotonin syndrome, characterized by confusion, tremor, and hyperthermia. Close monitoring or avoidance is recommended.
-
Is Loxapine safe for long-term use? Long-term therapy is generally well tolerated when monitored for extrapyramidal symptoms, metabolic changes, and cardiac rhythm. Regular follow-up visits enable early detection of adverse effects.
-
What information should I provide my doctor when discussing Loxapine?
- Complete list of current prescription and over-the-counter medications, including supplements.
- History of cardiac conditions, especially arrhythmias or prolonged QT interval.
- Any prior episodes of extrapyramidal symptoms or neuroleptic malignant syndrome.
- Pregnancy status or plans, and breastfeeding considerations.
Disclaimer
The information provided about Loxapine is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing Loxapine for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing Loxapine.